EM
Therapeutic Areas
Micar Innovation Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PPARγ Program | Metabolic Disorders | Discovery |
| AKT1 Inhibitor Program | Oncology | Discovery |
| GlyT2 Inhibitor Program | Neurological Disorders | Discovery |
| Cardiovascular Target Program | Hypertrophic Cardiomyopathy | Discovery |